Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.
Zattarin E, Presti D, Mariani L, Sposetti C, Leporati R, Menichetti A, Corti C, Benvenuti C, Fucà G, Lobefaro R, Ligorio F, Provenzano L, Vingiani A, Del Vecchio M, Griguolo G, Sirico M, Bernocchi O, Marra A, Zagami P, Agostinetto E, Jacobs F, Di Mauro P, Esposito A, Giorgi CA, Lalli L, Boldrini L, Giacchetti PPB, Schianca AC, Guarneri V, Pedersini R, Losurdo A, Zambelli A, Generali D, Criscitiello C, Curigliano G, Pruneri G, de Braud F, Dieci MV, Vernieri C. Zattarin E, et al. Among authors: agostinetto e. NPJ Breast Cancer. 2023 Apr 17;9(1):27. doi: 10.1038/s41523-023-00534-1. NPJ Breast Cancer. 2023. PMID: 37069173 Free PMC article.
[Complementary and alternative medicine in oncology].
Bozza C, Agostinetto E, Gerratana L, Puglisi F. Bozza C, et al. Among authors: agostinetto e. Recenti Prog Med. 2015 Dec;106(12):601-7. doi: 10.1701/2094.22648. Recenti Prog Med. 2015. PMID: 26780069 Review. Italian.
Reply to S. Di Cosimo et al.
Agostinetto E, Venet D, Ignatiadis M, Kalashnikova E. Agostinetto E, et al. JCO Precis Oncol. 2023 Jan;7:e2200644. doi: 10.1200/PO.22.00644. JCO Precis Oncol. 2023. PMID: 36701653 No abstract available.
Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients.
De Sanctis R, Agostinetto E, Masci G, Ferraro E, Losurdo A, Viganò A, Antunovic L, Zuradelli M, Torrisi RMC, Santoro A. De Sanctis R, et al. Among authors: agostinetto e. Oncology. 2018;94 Suppl 1(Suppl 1):19-28. doi: 10.1159/000489065. Epub 2018 Jul 23. Oncology. 2018. PMID: 30036884 Free PMC article.
Prognostic factors and outcome of HER2+ breast cancer with CNS metastases.
Masci G, Agostinetto E, Giordano L, Bottai G, Torrisi R, Losurdo A, De Sanctis R, Navarria P, Scorsetti M, Zuradelli M, de Rose F, Bello L, Santoro A. Masci G, et al. Among authors: agostinetto e. Future Oncol. 2020 Mar;16(7):269-279. doi: 10.2217/fon-2019-0602. Epub 2020 Feb 11. Future Oncol. 2020. PMID: 32043375
Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer.
Agostinetto E, Giordano L, Torrisi R, De Sanctis R, Masci G, Losurdo A, Zuradelli M, Tinterri C, Gatzemeier W, Testori A, Alloisio M, De Rose F, Fernandes B, Santoro A. Agostinetto E, et al. Clin Breast Cancer. 2020 Aug;20(4):e481-e489. doi: 10.1016/j.clbc.2020.02.011. Epub 2020 Mar 6. Clin Breast Cancer. 2020. PMID: 32279915
66 results